Related Experiment Video
Updated: Sep 3, 2025
09:19
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
9.1K
Special Issue "COVID-19 and Thrombosis"
Pierpaolo Di Micco1, Egidio Imbalzano2, Giuseppe Camporese3
1Uoc Medicina, P.O. A. Rizzoli-Asl Na2 Nord, Lacco Ameno, 80076 Naples, Italy.
Viruses
|July 27, 2022
Insights
The study found a link between COVID-19 and venous thromboembolism, especially in hospitalized patients. This highlights the importance of monitoring blood clot risks in those with the virus.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
Background:
- The ongoing COVID-19 pandemic has seen numerous reports associating the viral infection with venous thromboembolism (VTE).
- This association appears particularly pronounced in patients requiring hospitalization.
Discussion:
- Understanding the mechanisms linking SARS-CoV-2 infection to VTE is crucial for effective patient management.
- Investigating pre-existing risk factors and inflammatory responses in COVID-19 patients may elucidate VTE development.
Key Insights:
- COVID-19 infection is significantly associated with an increased risk of venous thromboembolism.
- Hospitalized COVID-19 patients represent a high-risk group for developing VTE.
- Further research is needed to fully understand the pathophysiology and implement targeted preventative strategies.
Outlook:
- Continued surveillance for VTE in COVID-19 patients is warranted.
- Development of novel therapeutic and prophylactic strategies targeting COVID-19-associated VTE is essential.
- Long-term studies may reveal persistent risks of VTE post-COVID-19 recovery.
Abstract:
Since the pandemic began, an association among COVID-19 and venous thromboembolism has been reported, in particular for inpatients [...].
Related Concept Videos
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
871
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
871
01:30Venous Thrombosis I: Introduction
37
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
37
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
30
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
30
01:29Venous Thrombosis III: Interprofessional Care
19
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
19
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K